These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 34450628)
1. A drug candidate for Alzheimer's and Huntington's disease, PBT2, can be repurposed to render Neisseria gonorrhoeae susceptible to natural cationic antimicrobial peptides. Jen FE; El-Deeb IM; Zalucki YM; Edwards JL; Walker MJ; von Itzstein M; Jennings MP J Antimicrob Chemother; 2021 Oct; 76(11):2850-2853. PubMed ID: 34450628 [TBL] [Abstract][Full Text] [Related]
2. Repurposing the Ionophore, PBT2, for Treatment of Multidrug-Resistant Neisseria gonorrhoeae Infections. Jen FE; Edwards JL; El-Deeb IM; Walker MJ; von Itzstein M; Jennings MP Antimicrob Agents Chemother; 2022 Sep; 66(9):e0231821. PubMed ID: 35980187 [TBL] [Abstract][Full Text] [Related]
4. Novel small molecules that increase the susceptibility of Neisseria gonorrhoeae to cationic antimicrobial peptides by inhibiting lipid A phosphoethanolamine transferase. Mullally C; Stubbs KA; Thai VC; Anandan A; Bartley S; Scanlon MJ; Jarvis GA; John CM; Lim KYL; Sullivan CM; Sarkar-Tyson M; Vrielink A; Kahler CM J Antimicrob Chemother; 2022 Aug; 77(9):2441-2447. PubMed ID: 35770844 [TBL] [Abstract][Full Text] [Related]
5. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995. Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980 [TBL] [Abstract][Full Text] [Related]
7. Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary. Brunner A; Nemes-Nikodem E; Mihalik N; Marschalko M; Karpati S; Ostorhazi E BMC Infect Dis; 2014 Aug; 14():433. PubMed ID: 25098185 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam. Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019. Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300 [TBL] [Abstract][Full Text] [Related]
10. High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998. Sosa J; Ramirez-Arcos S; Ruben M; Li H; Llanes R; Llop A; Dillon JA Sex Transm Dis; 2003 May; 30(5):443-8. PubMed ID: 12916137 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility and typing of Neisseria gonorrhoeae strains from Southern Spain, 2012-2014. Cobo F; Cabezas-Fernández MT; Cabeza-Barrera MI Enferm Infecc Microbiol Clin; 2016 Jan; 34(1):3-7. PubMed ID: 25735717 [TBL] [Abstract][Full Text] [Related]
12. Determining the in vitro susceptibility of Neisseria gonorrhoeae isolates from 8 cities in Guangdong Province through an improved microdilution method. Wu X; Qin X; Huang J; Wang F; Li M; Wu Z; Liu X; Pei J; Wu S; Chen H; Guo C; Xue Y; Tang S; Fang M; Lan Y; Ou J; Xie Z; Yu Y; Yang J; Chen W; Zhao Y; Zheng H Diagn Microbiol Infect Dis; 2018 Dec; 92(4):325-331. PubMed ID: 30292397 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent. Dillon JA; Li H; Sealy J; Ruben M; Prabhakar P; Sex Transm Dis; 2001 Sep; 28(9):508-14. PubMed ID: 11518867 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of Neisseria gonorrhoeae in Cuba (1995-1999): implications for treatment of gonorrhea. Llanes R; Sosa J; Guzmán D; Llop A; Valdés EA; Martínez I; Palma S; Lantero MI Sex Transm Dis; 2003 Jan; 30(1):10-4. PubMed ID: 12514435 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by Etest compared to Calibrated Dichotomous Sensitivity and Clinical Laboratory Standards Institute disc diffusion techniques. Mal PB; Jabeen K; Farooqi J; Unemo M; Khan E BMC Microbiol; 2016 Oct; 16(1):236. PubMed ID: 27724873 [TBL] [Abstract][Full Text] [Related]
16. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda. Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial agents and gonorrhoea: therapeutic choice, resistance and susceptibility testing. Ison CA Genitourin Med; 1996 Aug; 72(4):253-7. PubMed ID: 8976828 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone. Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572 [TBL] [Abstract][Full Text] [Related]